Fuso Pharmaceutical Industries,Ltd.(JP:4538)
Â¥2,194.00-7.00 (-0.32%)
JP:4538
Fuso Pharmaceutical Industries,Ltd. financials statements
Â¥2,194.00
At close:-7.00 (-0.32%)
Want to see JP:4538 full AI Analyst Report?
Fuso Pharmaceutical Industries,Ltd. (4538) Ratios
0 Followers
Fuso Pharmaceutical Industries,Ltd. Ratios
JP:4538's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:4538's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.11 | 1.10 | 1.52 | 1.52 | 1.51 |
| Quick Ratio | 0.81 | 0.76 | 1.04 | 1.08 | 1.11 |
| Cash Ratio | 0.09 | 0.14 | 0.17 | 0.28 | 0.28 |
| Solvency Ratio | 0.08 | -0.03 | 0.09 | 0.10 | 0.11 |
| Operating Cash Flow Ratio | -0.12 | -0.07 | 0.02 | 0.10 | 0.13 |
| Short-Term Operating Cash Flow Coverage | -0.23 | -0.18 | 0.11 | 0.41 | 0.55 |
| Net Current Asset Value | ¥ 2.07B | ¥ -1.13B | ¥ 5.81B | ¥ 6.40B | ¥ 4.98B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.26 | 0.17 | 0.17 | 0.17 |
| Debt-to-Equity Ratio | 0.81 | 0.64 | 0.35 | 0.35 | 0.35 |
| Debt-to-Capital Ratio | 0.45 | 0.39 | 0.26 | 0.26 | 0.26 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.07 | 0.16 | 0.14 | 0.14 |
| Financial Leverage Ratio | 2.58 | 2.50 | 2.07 | 2.03 | 2.01 |
| Debt Service Coverage Ratio | 0.18 | -0.07 | 0.65 | 0.57 | 0.62 |
| Interest Coverage Ratio | 8.05 | 25.66 | 11.49 | 13.37 | 10.93 |
| Debt to Market Cap | 1.41 | 1.02 | 0.68 | 0.72 | 0.63 |
| Interest Debt Per Share | 3371.74 | 2510.83 | 1497.35 | 1459.00 | 1398.49 |
| Net Debt to EBITDA | 4.39 | -5.04 | 1.81 | 1.00 | 1.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.67% | 26.73% | 24.40% | 26.94% | 26.99% |
| EBIT Margin | 4.44% | -7.94% | 3.50% | 4.65% | 4.21% |
| EBITDA Margin | 8.64% | -4.93% | 7.58% | 9.08% | 9.00% |
| Operating Profit Margin | 4.24% | 6.82% | 3.55% | 4.32% | 3.88% |
| Pretax Profit Margin | 3.91% | -8.21% | 3.19% | 4.32% | 3.85% |
| Net Profit Margin | 3.23% | -5.43% | 2.49% | 3.15% | 2.99% |
| Continuous Operations Profit Margin | 3.23% | -5.43% | 2.49% | 3.15% | 2.99% |
| Net Income Per EBT | 82.49% | 66.16% | 77.93% | 72.79% | 77.60% |
| EBT Per EBIT | 92.35% | -120.28% | 89.92% | 99.95% | 99.32% |
| Return on Assets (ROA) | 2.23% | -3.98% | 1.82% | 2.21% | 2.14% |
| Return on Equity (ROE) | 5.74% | -9.95% | 3.76% | 4.50% | 4.29% |
| Return on Capital Employed (ROCE) | 6.83% | 10.76% | 4.26% | 5.01% | 4.48% |
| Return on Invested Capital (ROIC) | 3.34% | 4.78% | 2.96% | 3.16% | 3.03% |
| Return on Tangible Assets | 2.26% | -4.06% | 1.83% | 2.22% | 2.15% |
| Earnings Yield | 9.97% | -15.76% | 7.39% | 9.17% | 7.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.32 | 2.29 | 2.28 | 2.35 | 2.35 |
| Payables Turnover | 6.54 | 5.14 | 2.55 | 2.54 | 5.94 |
| Inventory Turnover | 2.95 | 2.97 | 2.95 | 2.99 | 3.45 |
| Fixed Asset Turnover | 2.81 | 2.62 | 2.27 | 2.15 | 2.09 |
| Asset Turnover | 0.69 | 0.73 | 0.73 | 0.70 | 0.72 |
| Working Capital Turnover Ratio | 12.63 | 6.21 | 3.69 | 3.62 | 3.79 |
| Cash Conversion Cycle | 225.37 | 211.59 | 140.89 | 133.72 | 199.99 |
| Days of Sales Outstanding | 157.57 | 159.66 | 160.27 | 155.55 | 155.55 |
| Days of Inventory Outstanding | 123.59 | 122.90 | 123.75 | 121.91 | 105.87 |
| Days of Payables Outstanding | 55.79 | 70.97 | 143.13 | 143.74 | 61.44 |
| Operating Cycle | 281.16 | 282.56 | 284.02 | 277.47 | 261.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -728.92 | -386.87 | 72.82 | 325.27 | 398.75 |
| Free Cash Flow Per Share | -877.19 | -635.26 | -343.88 | 145.82 | 229.24 |
| Dividend Paid and CapEx Coverage Ratio | -3.11 | -1.20 | 0.15 | 1.36 | 1.74 |
| Capital Expenditure Coverage Ratio | -4.92 | -1.56 | 0.17 | 1.81 | 2.35 |
| Operating Cash Flow Coverage Ratio | -0.22 | -0.16 | 0.05 | 0.23 | 0.29 |
| Operating Cash Flow to Sales Ratio | -0.10 | -0.05 | 0.01 | 0.06 | 0.07 |
| Free Cash Flow Yield | -37.12% | -26.01% | -15.89% | 7.31% | 10.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.03 | -6.34 | 13.53 | 10.91 | 12.93 |
| Price-to-Sales (P/S) Ratio | 0.32 | 0.34 | 0.34 | 0.34 | 0.39 |
| Price-to-Book (P/B) Ratio | 0.58 | 0.63 | 0.51 | 0.49 | 0.56 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.69 | -3.84 | -6.29 | 13.69 | 9.54 |
| Price-to-Operating Cash Flow Ratio | -3.24 | -6.31 | 29.72 | 6.14 | 5.48 |
| Price-to-Earnings Growth (PEG) Ratio | -0.06 | 0.02 | -1.07 | 1.32 | -1.68 |
| Enterprise Value Multiple | 8.13 | -12.03 | 6.25 | 4.78 | 5.35 |
| Enterprise Value | 43.79B | 35.89B | 26.24B | 22.13B | 23.92B |
| EV to EBITDA | 8.13 | -12.03 | 6.25 | 4.78 | 5.35 |
| EV to Sales | 0.70 | 0.59 | 0.47 | 0.43 | 0.48 |
| EV to Free Cash Flow | -5.85 | -6.61 | -8.86 | 17.30 | 11.90 |
| EV to Operating Cash Flow | -7.04 | -10.86 | 41.84 | 7.76 | 6.84 |
| Tangible Book Value Per Share | 3947.72 | 3691.09 | 4187.99 | 4026.88 | 3884.71 |
| Shareholders’ Equity Per Share | 4105.70 | 3867.85 | 4257.67 | 4064.38 | 3936.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.17 | 0.34 | 0.22 | 0.27 | 0.22 |
| Revenue Per Share | 7297.09 | 7089.20 | 6434.65 | 5816.28 | 5657.78 |
| Net Income Per Share | 235.52 | -384.88 | 159.92 | 182.99 | 169.05 |
| Tax Burden | 0.82 | 0.66 | 0.78 | 0.73 | 0.78 |
| Interest Burden | 0.88 | 1.03 | 0.91 | 0.93 | 0.91 |
| Research & Development to Revenue | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 |
| SG&A to Revenue | 0.21 | 0.17 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -3.09 | 1.01 | 0.35 | 1.29 | 1.83 |
Currency in JPY

